In vitro activities of four novel triazoles against Scedosporium spp.

被引：137
|
作者：
Carrillo, AJ
Guarro, J
机构：
[1] Univ Rovira & Virgili, Fac Med, Unitat Microbiol, E-43201 Reus, Spain
[2] Univ Rovira & Virgili, Inst Estudis Avancats, E-43201 Reus, Spain
[3] Asesoria Cient & Invest Aplicada, Dept Microbiol, Barcelona 08037, Spain
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2001年 / 45卷 / 07期
关键词：
D O I：
10.1128/AAC.45.7.2151-2153.2001
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
In order to develop new approaches to the treatment of the severe and usually fatal infections caused by Scedosporium spp., the in vitro antifungal activities of four novel triazoles (posaconazole, ravuconazole, voriconazole, and UR-9825) and some current antifungals (amphotericin B, ketoconazole, itraconazole, and nystatin) were determined. The latter group was clearly ineffective against the two species tested. The four new antifungals showed activity against Scedosporium apiospermum, and UR-9825 and voriconazole were active against S. prolificans.
引用
收藏
页码：2151 / 2153
页数：3
相关论文
共 50 条
  • [1] An in vitro assessment of antifungal activities of novel triazoles against common Trichophyton spp., causing onychomycosis in Tehran, Iran
    Rezaei-Matehkolaei, A.
    Khodavaisy, S.
    Makimura, K.
    Alshahni, M.
    Tamura, T.
    Taghipour, S.
    Abastabar, M.
    Shokohi, G.
    MYCOSES, 2017, 60 : 54 - 54
  • [2] In Vitro Activities of Hexaazatrinaphthylenes against Leishmania spp.
    Lopez-Arencibia, Atteneri
    Garcia-Velazquez, Daniel
    Martin-Navarro, Carmen M.
    Sifaoui, Ines
    Reyes-Batlle, Maria
    Lorenzo-Morales, Jacob
    Gutierrez-Ravelo, Angel
    Pinero, Jose E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (05) : 2867 - 2874
  • [3] In Vitro and In Vivo Effect of the Imidazole Luliconazole against Lomentospora prolificans and Scedosporium spp.
    Furnica, Dan-Tiberiu
    Dittmer, Silke
    Scharmann, Ulrike
    Meis, Jacques F.
    Steinmann, Joerg
    Rath, Peter-Michael
    Kirchhoff, Lisa
    MICROBIOLOGY SPECTRUM, 2023, 11 (03)
  • [4] In vitro synergistic interaction between amphotericin B and micafungin against Scedosporium spp.
    Yustes, C
    Guarro, J
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (08) : 3498 - 3500
  • [5] In vitro inhibitory activities of magnolol against Candida spp.
    Zhou, Peiru
    Fu, Jingya
    Hua, Hong
    Liu, Xiaosong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2653 - 2661
  • [6] In vitro and in vivo activities of sitafloxacin against Chlamydia spp.
    Miyashita, N
    Niki, Y
    Matsushima, T
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (11) : 3270 - 3272
  • [7] In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis, RE
    Wiederhold, NP
    Klepser, ME
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (03) : 945 - 951
  • [8] In vitro antifungal and antibiofilm activities of novel sulfonyl hydrazone derivatives against Candida spp.
    Aydin, Merve
    Ozturk, Ali
    Duran, Tugce
    Ozmen, Ummuhan Ozdemir
    Sumlu, Esra
    Ayan, Esra Bilen
    Korucu, Emine Nedime
    JOURNAL DE MYCOLOGIE MEDICALE, 2023, 33 (01):
  • [9] In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp.
    Compain, Fabrice
    Botterel, Francoise
    Sitterle, Emilie
    Paugam, Andre
    Bougnoux, Marie-Elisabeth
    Dannaoui, Eric
    JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 64 : 309 - 311
  • [10] Infections caused by Scedosporium spp.
    Cortez, Karoll J.
    Roilides, Emmanuel
    Quiroz-Telles, Flavio
    Meletiadis, Joseph
    Antachopoulos, Charalampos
    Knudsen, Tena
    Buchanan, Wendy
    Milanovich, Jeffrey
    Sutton, Deanna A.
    Fothergill, Annette
    Rinaldi, Michael G.
    Shea, Yvonne R.
    Zaoutis, Theoklis
    Kottilil, Shyam
    Walsh, Thomas J.
    CLINICAL MICROBIOLOGY REVIEWS, 2008, 21 (01) : 157 - +
12345